Warberg Asset Management »

Reviva Pharmaceu shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Reviva Pharmaceu (RVPH) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Reviva Pharmaceu

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceu held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceu by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $66k 91k 0.73

More positions owned by Warberg Asset Management

State Str Spdr S&p 500 Etf T Put Put Option
Lumentum Hldgs Note 0.500%12/1 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Microchip Technology Note 1.625% 2/1 (Principal)
Invesco Qqq Tr Put Put Option
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Wisdomtree Note 3.250% 6/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Lci Inds Note 3.000% 3/0 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Cornerstone Strategic Value (CLM)
Txnm Energy Note 5.750% 6/0 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Reviva Pharmaceu

Millennium Management
Jpmorgan Chase & Co
Armistice Capital
GSA Capital Partners
EMC Capital Management
Vanguard Capital Management
Warberg Asset Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Hrt Financial
Castleview Partners
Two Sigma Investments
Morgan Stanley
UBS Group

View all funds holding Reviva Pharmaceu